BorgWarner (BWA) Form 144: Proposed Sale of 8,772 Shares ($371K)
BorgWarner Inc. (BWA) filed a Form 144 notice for a proposed sale of 8,772 common shares through Charles Schwab & Co., Inc., with an aggregate market value of $371,184 and an approximate sale date of 09/02/2025 on the NYSE.
Rhea-AI Filing Summary
BorgWarner Inc. (BWA) filed a Form 144 notice for a proposed sale of 8,772 common shares through Charles Schwab & Co., Inc., with an aggregate market value of $371,184 and an approximate sale date of 09/02/2025 on the NYSE. The filing lists the acquisition sources and dates for the shares to be sold: restricted stock lapses on 04/24/2024 (3,752 shares) and 04/24/2025 (4,903 shares), and dividend payouts on 04/24/2024 (48 shares) and 04/24/2025 (69 shares); all were received from BorgWarner Inc. and paid as equity compensation. The filer reports no securities sold in the past three months and certifies no undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR Routine insider sale notice specifying 8,772 shares (~$371k) sourced from equity compensation; no recent sales reported.
The Form 144 documents a proposed sale under Rule 144 of 8,772 common shares via Charles Schwab, valued at $371,184, with proceeds arising from equity compensation events dated 04/24/2024 and 04/24/2025. The filing states no securities were sold in the prior three months. This is a standard disclosure required for restricted or control securities being sold into the public market and does not, by itself, indicate material corporate change.
TL;DR Disclosure meets Rule 144 procedural requirements; shows compensation-related share vesting and planned sale through a broker.
The notice identifies the broker (Charles Schwab & Co., Inc.), the exchange (NYSE), and the exact lot-level acquisition history (restricted stock lapses and dividend payout dates and quantities). The filer attests to lack of undisclosed material adverse information. From a governance perspective, this provides transparency about insider liquidity sourced from equity compensation but contains no evidence of unusual timing or aggregation of recent sales.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does BorgWarner's Form 144 filed under symbol BWA disclose?
Does the filing report any sales of BorgWarner securities in the past three months?
Which broker and exchange are involved in the proposed BWA sale?
Does the filer assert any undisclosed material information in the Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.